NL265428A - - Google Patents

Info

Publication number
NL265428A
NL265428A NL265428DA NL265428A NL 265428 A NL265428 A NL 265428A NL 265428D A NL265428D A NL 265428DA NL 265428 A NL265428 A NL 265428A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL265428A publication Critical patent/NL265428A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42Separation; Purification; Stabilisation; Use of additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04Acids; Metal salts or ammonium salts thereof
    • C08F220/06Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
NL265428D 1960-06-06 NL265428A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33896A US3074852A (en) 1960-06-06 1960-06-06 Pharmaceuticals with delayed release

Publications (1)

Publication Number Publication Date
NL265428A true NL265428A (xx)

Family

ID=21873090

Family Applications (2)

Application Number Title Priority Date Filing Date
NL128902D NL128902C (xx) 1960-06-06
NL265428D NL265428A (xx) 1960-06-06

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL128902D NL128902C (xx) 1960-06-06

Country Status (9)

Country Link
US (1) US3074852A (xx)
BE (1) BE604564A (xx)
DE (1) DE1279896C2 (xx)
ES (1) ES267532A1 (xx)
FI (1) FI40562B (xx)
FR (1) FR1409M (xx)
GB (1) GB905000A (xx)
NL (2) NL265428A (xx)
SE (1) SE328372B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636865A (xx) * 1962-08-31
US3330729A (en) * 1963-10-04 1967-07-11 Goodrich Co B F Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3619200A (en) * 1966-06-21 1971-11-09 Commw Scient Ind Res Org Method and food composition for feeding ruminants
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
US4248857A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309404A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
IN151913B (xx) * 1980-01-11 1983-09-03 Boots Co Ltd
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
CH672922A5 (xx) * 1987-09-25 1990-01-15 Battelle Memorial Institute
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
JPH02212416A (ja) * 1988-12-22 1990-08-23 Monsanto Co 薬物用の膨潤制御経口送達システム
ATE113841T1 (de) 1989-10-31 1994-11-15 Columbia Lab Inc Mittel zur feuchthaltung vaginalen gewebes.
US5498410A (en) * 1991-04-22 1996-03-12 Gleich; Gerald J. Method for the treatment of eosinophil-associated conditions with anionic polymers
US5250293A (en) * 1991-04-22 1993-10-05 Gleich Gerald J Method for the treatment of hypersensitivity diseases by administration of anionic polymers
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US20010006644A1 (en) * 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
IN186245B (xx) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CA2431205C (en) * 2000-12-05 2005-08-23 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
MXPA06002841A (es) * 2003-09-30 2006-06-14 Lupin Ltd Formulacion de liberacion prolongada novedosa de antibioticos de (-lactama.
JP4757872B2 (ja) * 2004-08-13 2011-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその医薬品として許容される塩を含む放出が延長された錠剤調合物、その製造方法及びその使用
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
CN101229378A (zh) * 2005-05-05 2008-07-30 国家淀粉及化学投资控股公司 用于送递活性剂的组合物
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE631201C (de) * 1932-08-07 1936-06-16 Chemische Forschungs Gmbh Traegerstoff fuer Arzneimittel
DE644759C (de) * 1932-11-23 1937-05-12 I G Farbenindustrie Akt Ges Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
BE575343A (xx) * 1955-09-09
US2912358A (en) * 1955-11-02 1959-11-10 Bristol Myers Co Antacid preparations containing acrylic acid polymers and magnesium antacids
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US2854381A (en) * 1955-12-08 1958-09-30 Bristol Myers Co Resin laxative tablets containing hydrolyzed keratin
US2887436A (en) * 1956-05-28 1959-05-19 Pfizer & Co C Pharmaceutical compositions
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US2887439A (en) * 1956-09-28 1959-05-19 Pfizer & Co C Palatable antihistamine tablet
DE1070381B (de) * 1957-03-15 1959-12-03 Rohm & LIaas Company, Philadelphia, Pa. (V. St. A.) Verfahren zur Herstellung von Ionenaustauscherharzen auf Basis der Acrylsäuren und Methacrylsäuren
NL230864A (xx) * 1957-08-27
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations
NL109170C (xx) * 1958-02-03
US2957804A (en) * 1958-06-06 1960-10-25 Harlan R Shuyler Pesticide
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3033754A (en) * 1959-12-21 1962-05-08 Lakeside Lab Inc Tablets containing hydrazine derivatives

Also Published As

Publication number Publication date
ES267532A1 (es) 1961-11-16
SE328372B (xx) 1970-09-14
FR1409M (fr) 1962-07-23
DE1279896B (de) 1968-10-10
BE604564A (xx)
GB905000A (en) 1962-09-05
DE1279896C2 (de) 1974-03-14
FI40562B (xx) 1968-11-30
NL128902C (xx)
US3074852A (en) 1963-01-22

Similar Documents

Publication Publication Date Title
JPS4828553B1 (xx)
FI44086B (xx)
FR920M (xx)
IT649594A (xx)
FI40164B (xx)
FI41270B (xx)
FR822M (xx)
FR1579453A (xx)
FR779M (xx)
FR878M (xx)
FR95M (xx)
FR62M (xx)
IT649856A (xx)
NL109717C (xx)
BE609362A (xx)
BE609046A (xx)
BE606732A (xx)
BE606549A (xx)
CH113860A4 (xx)
CH1092761A4 (xx)
BE606041A (xx)
BE605487A (xx)
BE592051A (xx)
NL121699C (xx)
BE604945A (xx)